Added to YB: 2024-04-03
Pitch date: 2024-03-31
MOB.ST [bullish]
Moberg Pharma AB (publ)
-60.89%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden.
Market Cap
SEK 448.5M
Pitch Price
SEK 23.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.33
P/E
-17.42
EV/Sales
16.30
Sector
Pharmaceuticals
Category
growth
Show full summary:
Moberg Pharma - My Research Notes
Moberg Pharma (MOB.ST): High risk, high reward play on MOB-015 for onychomycosis. Partners like Bayer in EU, Cipher in Canada project strong sales. US expansion is key, could do 150-300M+ USD/yr at high margins but approval & launch timing uncertain. Fully diluted MCap 99M USD.
Read full article (4 min)